Last $65.91 USD
Change Today +0.11 / 0.17%
Volume 5.1M
LLY On Other Exchanges
Symbol
Exchange
New York
Mexico
SIX Swiss Ex
Sao Paulo
EN Paris
Frankfurt
As of 8:04 PM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jan M. Lundberg Ph.D.

Executive Vice President of Science & Technology and President of Lilly Research Laboratories, Eli Lilly and Company
AgeTotal Calculated CompensationThis person is connected to 118 board members in 2 different organizations across 4 different industries.

See Board Relationships
60$4,774,535
As of Fiscal Year 2013

Background*

Dr. Jan M. Lundberg, Ph.D. has been President of Lilly Research Laboratories and Executive Vice President of Science & Technology at Eli Lilly and Company since January 2010. Dr. Lundberg served as Executive Vice President and Head of Discovery Research at AstraZeneca PLC since 2002 until January 2010. He has an extensive research experience. He served as the Head of Preclinical Affairs of Astra AB, with responsibilities for Discovery build up of enabling technologies, ...

Read Full Background

Corporate Headquarters*

Lilly Corporate Center
Indianapolis, Indiana 46285

United States

Phone: 317-276-2000
Fax: --

Board Members Memberships*

Director
Member of Board of Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

Salary$1,002,963
Total Annual Compensation$1,002,963

Stock Options*

Restricted Stock Awards$2,250,000
All Other Compensation$60,178

Total Compensation*

Total Annual Cash Compensation$2,299,794
Total Short Term Compensation$1,002,963
Other Long Term Compensation$2,310,178
Total Calculated Compensation$4,774,535
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LLY:US $65.91 USD +0.11

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELI LILLY & CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.